Reduced Intensity Allogeneic Transplantation Combined with Prophylactic/Pre-Emptive Usage of Donor Lymphocyte Infusion Enables Durable Disease-Free Survival in Older Patients with Myeloid Disease

Abstract

Abstract is not available.